Insiders ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 05/12/2025 GMT			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Insiders

Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	12-04	MT
LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	12-02	CI
ResMed Inc. Announces Not Seek Re-Election of Richard Sulpizio to the Board of Directors, Effective November 19, 2025	11-25	CI
ResMed Insider Sold Shares Worth $2,000,773, According to a Recent SEC Filing	11-11	MT
ResMed CFO Buys, Sells Shares	11-05	MT
Resmed Insider Sold Shares Worth $742,620, According to a Recent SEC Filing	11-04	MT
ResMed CFO Sells Shares	11-03	MT
NZX Announces Executive Changes	10-15	CI
PolyNovo Limited Announces Appointment of Robert Douglas to the Board of Directors	10-14	CI
ResMed Insider Sold Shares Worth $2,265,332, According to a Recent SEC Filing	10-09	MT
Resmed Insider Sold Shares Worth $823,080, According to a Recent SEC Filing	10-03	MT
Resmed announces election of Nicole Mowad-Nassar to board, upcoming retirement of Rich Sulpizio	08-18	RE
ResMed Inc. Announces Board Changes	08-18	CI
ResMed Insider Sold Shares Worth $2,238,379, According to a Recent SEC Filing	08-11	MT
Resmed Insider Sold Shares Worth $845,700, According to a Recent SEC Filing	08-05	MT
Resmed Inc. Announces Resignation of Bobby Ghoshal as Chief Commercial Officer, Residential Care Software Business, Effective August 1, 2025	08-01	CI
Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing	07-09	MT
ResMed Insider Sold Shares Worth $997,892, According to a Recent SEC Filing	07-02	MT
Resmed Insider Sold Shares Worth $494,640, According to a Recent SEC Filing	06-06	MT
Resmed Insider Sold Shares Worth $891,286, According to a Recent SEC Filing	05-27	MT
Resmed Insider Sold Shares Worth $486,940, According to a Recent SEC Filing	05-22	MT
Resmed Insider Sold Shares Worth $1,948,003, According to a Recent SEC Filing	05-09	MT
Resmed Insider Sold Shares Worth $484,500, According to a Recent SEC Filing	05-08	MT
ResMed Appoints Salli Schwartz as Chief Investor Relations Officer	04-22	MT
Resmed Names Salli Schwartz as Chief Investor Relations Officer Effective April 21, 2025	04-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed's innovation-driven success and prospects

October 31, 2025 at 08:55 am